Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

Ítems similars

• TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
  per: Tefferi, A, et al.
  Publicat: (2009)
• Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
  per: Tefferi, Ayalew, et al.
  Publicat: (2014)
• Targeted deep sequencing in polycythemia vera and essential thrombocythemia
  per: Tefferi, Ayalew, et al.
  Publicat: (2016)
• Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial
  per: Pardanani, A, et al.
  Publicat: (2015)
• Significance of thrombocytopenia in patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
  per: Masarova, Lucia, et al.
  Publicat: (2018)